MIM
ONSIW

Monashee Investment Management’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

Monashee Investment Management’s Portfolio ONSIW Stock Details ONSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-25,000
Closed -$920 – 153
2018
Q1 		$1K Buy
+25,000
New +$1.01K ﹤0.01% 140
2017
Q4 		– Hold
0
– – – 133
2017
Q3 		– Sell
-25,000
Closed -$3.19K – 80
2017
Q2 		$4K Buy
+25,000
New +$12.3K ﹤0.01% 83
2017
Q1 		– Sell
-25,000
Closed -$10.6K – 80
2016
Q4 		$5K Buy
+25,000
New +$7.93K ﹤0.01% 84
2016
Q3 		– Hold
0
– – – 86
2016
Q2 		– Hold
0
– – – 56

Other funds holding ONSIW

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Monashee Investment Management's ONSIW Position: Q2 2018 in Review

Monashee Investment Management sold out of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q2 2018, closing a stake of 25,000 shares — an estimated $920 sold.

Monashee Investment Management first reported a position in ONSIW in Q4 2016 and held it in 3 quarters. The position peaked at $5K in Q4 2016. 7 funds tracked by Wall St. Rank hold ONSIW as of Q2 2018.

  • Monashee Investment Management reported no remaining Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position as of Q2 2018 after selling out during the quarter.
  • Monashee Investment Management sold 25,000 Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 shares in Q2 2018, an estimated $920.
  • Monashee Investment Management first reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in Q4 2016 and held it in 3 quarters.
  • Monashee Investment Management's Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position peaked at $5K in Q4 2016.
  • 7 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q2 2018.

Based on Monashee Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.